CRISPR Therapeutics Milestones And ARK Backing Contrast With Valuation Gap [Yahoo! Finance]
CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Citizens Jmp from $86.00 to $80.00. They now have a "market outperform" rating on the stock.
CRISPR Therapeutics (NASDAQ:CRSP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch [Yahoo! Finance]
BofA is Bullish on CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]